We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Beroni Group has provided an update on the development of the previously announced potential medical solution utilizing nanobody technology for both detection and treatment of COVID-19 in collaboration with Tianjin University in China.
Belgian biotech Ablynx just signed a potentially lucrative new deal with Sanofi that could be worth an eye-watering €2.4 billion, although just €23 million of that comes up front.